Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10901
Harvard Bioscience
HBIO
$37.4M
| $145K | ﹤0.01% |
6,872
-4,727
| -41% | -$109K |
2024 Q1
3 quarters
|
|
10902
CALL
NerdWallet
NRDS
$610M
| $145K | ﹤0.01% |
10,900
-13,500
| -55% | -$180K |
2021 Q4
12 quarters
|
|
10903
Procure Space ETF
UFO
$531M
| $145K | ﹤0.01% |
+6,240
| New | +$133K |
2024 Q4
0 quarters
|
|
|
WIMI
10904
CALL
WiMi Hologram Cloud
WIMI
$11.8M
| $145K | ﹤0.01% |
7,830
+4,870
| +165% | +$46.6K |
2020 Q4
16 quarters
|
|
10905
Hooker Furnishings Corp
HOFT
$136M
| $145K | ﹤0.01% |
+10,337
| New | +$174K |
2024 Q4
0 quarters
|
|
10906
CALL
Pulse Biosciences
PLSE
$3.53B
| $145K | ﹤0.01% |
8,300
-3,600
| -30% | -$63.5K |
2023 Q3
5 quarters
|
|
10907
Zura Bio
ZURA
$384M
| $144K | ﹤0.01% |
57,779
-279,049
| -83% | -$994K |
2023 Q2
6 quarters
|
|
10908
CALL
Varex Imaging
VREX
$784M
| $144K | ﹤0.01% |
9,900
-11,300
| -53% | -$158K |
2022 Q4
8 quarters
|
|
|
ORGN
10909
CALL
DELISTED
Origin Materials
ORGN
| $144K | ﹤0.01% |
3,760
-4,647
| -55% | -$176K |
2021 Q1
15 quarters
|
|
10910
CALL
Quad
QUAD
$485M
| $144K | ﹤0.01% |
20,700
+1,900
| +10% | +$12.9K |
2022 Q2
10 quarters
|
|
10911
PUT
AerSale
ASLE
$239M
| $144K | ﹤0.01% |
22,900
-70,600
| -76% | -$405K |
2021 Q4
12 quarters
|
|
10912
CALL
ProShares UltraShort Real Estate
SRS
$17.6M
| $144K | ﹤0.01% |
2,775
+800
| +41% | +$38K |
2022 Q2
10 quarters
|
|
|
FOCL
10913
EDAP TMS S.A.
FOCL
$197M
| $144K | ﹤0.01% |
65,242
+28,679
| +78% | +$71.9K |
2022 Q2
10 quarters
|
|
10914
US Global Investors
GROW
$35.3M
| $144K | ﹤0.01% |
59,062
+11,009
| +23% | +$27K |
2021 Q1
15 quarters
|
|
|
FIRY
10915
Firy Inc
FIRY
$198M
| $144K | ﹤0.01% |
+28,647
| New | +$153K |
2024 Q4
0 quarters
|
|
|
KWY
10916
Kingsway Corp
KWY
$275M
| $144K | ﹤0.01% |
+17,213
| New | +$151K |
2024 Q4
0 quarters
|
|
10917
Acacia Research
ACTG
$427M
| $144K | ﹤0.01% |
33,170
+20,814
| +168% | +$94.3K |
2022 Q4
8 quarters
|
|
10918
PUT
Steris
STE
$20.4B
| $144K | ﹤0.01% |
700
| – | – |
2020 Q2
18 quarters
|
|
10919
Tradr 2X Long Innovation ETF
TARK
$16.6M
| $144K | ﹤0.01% |
3,294
-2,706
| -45% | -$110K |
2023 Q1
7 quarters
|
|
10920
CALL
Perspective Therapeutics
CATX
$297M
| $144K | ﹤0.01% |
45,000
+43,100
| +2,268% | +$352K |
2024 Q3
1 quarter
|
|
|
ACCS
10921
ACCESS Newswire
ACCS
$17.5M
| $144K | ﹤0.01% |
+16,055
| New | +$159K |
2024 Q4
0 quarters
|
|
10922
CALL
Rockwell Medical
RMTI
$32.8M
| $143K | ﹤0.01% |
7,030
+2,800
| +66% | +$81.7K |
2022 Q4
8 quarters
|
|
10923
CALL
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11B
| $143K | ﹤0.01% |
4,000
-2,700
| -40% | -$101K |
2024 Q3
1 quarter
|
|
|
NFGC
10924
PUT
New Found Gold
NFGC
$592M
| $143K | ﹤0.01% |
78,700
-500
| -0.6% | -$1.02K |
2022 Q4
8 quarters
|
|
10925
Standard BioTools
LAB
$259M
| $143K | ﹤0.01% |
81,589
+15,919
| +24% | +$29.7K |
2024 Q2
2 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.